Results 161 to 170 of about 810,344 (312)

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Operationalizing the Ottawa Charter for Health Promotion in Thailand: the role of ThaiHealth. [PDF]

open access: yesHealth Promot Int
Wongwatcharapaiboon P   +4 more
europepmc   +1 more source

Other title: Behavioral Risk Factor Surveillance System

open access: yes, 1990
Acknowledgements Table of Contents Introduction Executive Summary Methodology Survey Results Safety Belt Use/Non Use Hypertension Obesity Sedentary Lifestyle Tobacco Use High Blood Cholesterol Nutrition Alcohol Use Health Insurance AIDS Women's Health ...
Kansas. Bureau of Health Promotion.
core  

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

CDC health risk appraisal user manual [PDF]

open access: yes
In 1977, the Bureau of Health Education (currently the Center for Health Promotion and Education) at the Centers for Disease Control (CDC) established a cooperative relationship with Health and Welfare Canada. This relationship allowed the CDC to acquire

core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Uvodnik: mednarodni dan medicinskih sester 1998. partnerstvo za zdravo skupnost

open access: yesObzornik zdravstvene nege, 1998
Health Promotion   +2 more
doaj  

Key functions for the transferability of a French school-based health promotion intervention. [PDF]

open access: yesPLoS One
Sartori I   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy